Literature DB >> 28029083

Psychopathological Behaviour and Cognition in Morbid Obesity.

Alba Calderone1, Pasquale Fabio Calabro1, Chita Lippi1, Roberta Jaccheri1, Jacopo Vitti1, Ferruccio Santini1.   

Abstract

BACKGROUND: Obesity is a chronic condition with high prevalence and multifaceted aetiology, accompanied by an increased risk of morbidity and mortality. Obesity has several negative effects on the psychological status, and the severity of psychological disorders correlates with the degree of obesity.
OBJECTIVE: Aim of this review is to provide an overview of the literature concerning the psychological distress associated with severe obesity, which contributes to deterioration of the quality of life of affected patients.
METHODS: Dysfunctional eating behaviours and eating disorders, psychiatric comorbidity, cognition and quality of life will be discussed together with the most common drugs that can be employed to treat the various disorders in this peculiar clinical setting. The effects of bariatric surgery will be also reviewed.
RESULTS: Obesity is often the result of pathological behaviours implemented in an eating disorder. Inconsistent results have been reported with regard to the effect of severe obesity on cognition, which recognize a multifaceted aetiology. Serotonergic agents play an important role in the management of patients with obesity and binge episodes, fluoxetine being currently a drug approved for this disorder. The efficacy of lorcaserin, a combination of bupropion and naltrexone, or antiepileptic medications (topiramate and zonisamide) has also been proposed. A neuroprotective role of leptin and oestrogen has been hypothesized. Bariatric surgery is a helpful treatment of morbid obese patients, with long-term favourable results on the psychopathological profile.
CONCLUSION: Psychological, psychoeducational and psychopharmacological treatment can facilitate weight loss in morbid obese subjects with psychopathological comorbidities. A precise definition of the mechanisms affecting appetite, satiety and energy balance is expected to foster the development of new effective antiobesity drugs. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Antiobesity drugs; bariatric surgery; cognitive-behavioural therapy; eating disorders; morbid obesity; neurocognitivezzm321990disease; quality of life.

Mesh:

Substances:

Year:  2017        PMID: 28029083     DOI: 10.2174/1872214810666161226162823

Source DB:  PubMed          Journal:  Recent Pat Endocr Metab Immune Drug Discov        ISSN: 1872-2148


  2 in total

Review 1.  Obesity-An Update on the Basic Pathophysiology and Review of Recent Therapeutic Advances.

Authors:  Erind Gjermeni; Anna S Kirstein; Florentien Kolbig; Michael Kirchhof; Linnaeus Bundalian; Julius L Katzmann; Ulrich Laufs; Matthias Blüher; Antje Garten; Diana Le Duc
Journal:  Biomolecules       Date:  2021-09-29

2.  Effectiveness of an Interdisciplinary Program Performed on Obese People Regarding Nutritional Habits and Metabolic Comorbidity: A Randomized Controlled Clinical Trial.

Authors:  Virginia Esperanza Fernández-Ruiz; Antonio Jesús Ramos-Morcillo; María Solé-Agustí; José Antonio Paniagua-Urbano; David Armero-Barranco
Journal:  Int J Environ Res Public Health       Date:  2020-01-03       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.